{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:26:36Z","timestamp":1791505596495,"version":"4.3.4"},"reference-count":75,"publisher":"SAGE Publications","issue":"9","license":[{"start":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T00:00:00Z","timestamp":1747008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Psychopharmacol"],"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:p>Psychedelics offer promising outcomes in psychiatry. However, the preparation of participants (set) and the environmental conditions of taking a psychedelic (setting) are not standardized. We describe the set and setting for therapeutic use of psychedelic drugs in people with psychiatric disorders. In this systematic review, articles were identified in the PubMed and Web of Science databases until 12 December 2023. Only clinical trials published in English or French were eligible, and studies using psychedelics for withdrawal were excluded. Sixteen domains of set and setting were assessed covering participant selection, pre- and post-session interventions, monitor presence, environmental management, and end-of-session procedure. Of 4912 articles screened, 27 articles were retained reporting on 25 studies. Thirteen of the included studies reported randomized trials, while 12 were open-label studies, on a total of 763 participants. Studies considered features of set and setting to different extents. Participant selection and the creation of a safe environment were consistently present, but articles were more heterogeneous about reporting monitor training (52%), controlling visual distractors (64%) and creating a pleasant environment (68%). Psilocybin was over-represented (47%). Many key elements were described in each study, but differences in set and setting limit comparability and reproducibility. Harmonizing these aspects would aid the interpretation of future studies and help understand the effect of psychedelics in psychiatry.<\/jats:p>","DOI":"10.1177\/02698811251338214","type":"journal-article","created":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T07:39:27Z","timestamp":1747035567000},"page":"910-929","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":17,"title":["Set and setting of psychedelics for therapeutic use in psychiatry: A systematic review"],"prefix":"10.1177","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5498-7566","authenticated-orcid":false,"given":"Cl\u00e9mentine","family":"Estric","sequence":"first","affiliation":[{"name":"Department of Psychiatry, CHU N\u00eemes, University of Montpellier, N\u00eemes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Duron","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, CH Thuir, Thuir, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Kabani","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Epidemiology, Public Health and Innovation in Methodology (BESPIM), CHU N\u00eemes, University of Montpellier, N\u00eemes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Lopez-Castroman","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, CHU N\u00eemes, University of Montpellier, N\u00eemes, France"},{"name":"Department of Psychiatry, Public Health, Radiology, Nursing and Medicine, University of Santiago de Compostela, Santiago de Compostela, Spain"},{"name":"Centro de Investigacion Biom\u00e9dica en Red de Salud Mental, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,5,12]]},"reference":[{"key":"e_1_3_3_2_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2023.4685"},{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/acps.13249"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881115609019"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881116678781"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-41145-x"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1089\/jpm.2017.0684"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881116662634"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2017.84"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(16)30065-7"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881118754710"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2032994"},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyg.2022.887255"},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.1177\/02698811241308613"},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2020.3285"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt196563279"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1177\/2045125316638008"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1080\/17512433.2018.1511424"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000001428"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41386-022-01344-y"},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2019.00650"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-014-3664-5"},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.1097\/NMD.0000000000000113"},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.1017\/S003329172000389X"},{"key":"e_1_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.1007\/7854_2021_298"},{"key":"e_1_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2206443"},{"key":"e_1_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41386-023-01648-7"},{"key":"e_1_3_3_28_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.1659-20.2020"},{"key":"e_1_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881108094300"},{"key":"e_1_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-011-2358-5"},{"key":"e_1_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881116675513"},{"key":"e_1_3_3_32_1","doi-asserted-by":"publisher","DOI":"10.1001\/archgenpsychiatry.2010.116"},{"key":"e_1_3_3_33_1","doi-asserted-by":"crossref","unstructured":"Guss J Krause R Sloshower J (2020) The Yale Manual for Psilocybin-Assisted Therapy of Depression (Using Acceptance and Commitment Therapy as a Therapeutic Frame). Available at: https:\/\/osf.io\/u6v9y_v1","DOI":"10.31234\/osf.io\/u6v9y"},{"key":"e_1_3_3_34_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.00897"},{"key":"e_1_3_3_35_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g1687"},{"key":"e_1_3_3_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2022.08.025"},{"key":"e_1_3_3_37_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881108093587"},{"key":"e_1_3_3_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2018.05.012"},{"key":"e_1_3_3_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2018.11.010"},{"key":"e_1_3_3_40_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-017-4820-5"},{"key":"e_1_3_3_41_1","doi-asserted-by":"publisher","DOI":"10.1177\/02698811241257839"},{"key":"e_1_3_3_42_1","doi-asserted-by":"publisher","DOI":"10.1556\/2054.2022.00222"},{"key":"e_1_3_3_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2023.06.006"},{"key":"e_1_3_3_44_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41386-023-01607-2"},{"key":"e_1_3_3_45_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v67n1110"},{"key":"e_1_3_3_46_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.788155"},{"key":"e_1_3_3_47_1","doi-asserted-by":"publisher","DOI":"10.1124\/pr.115.011478"},{"key":"e_1_3_3_48_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2022.965641"},{"key":"e_1_3_3_49_1","doi-asserted-by":"publisher","DOI":"10.1590\/1516-4446-2014-1496"},{"key":"e_1_3_3_50_1","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al. (2021) The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ 372: n71.","journal-title":"BMJ"},{"key":"e_1_3_3_51_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291718001356"},{"key":"e_1_3_3_52_1","unstructured":"Pathways C (n.d.) COMPASS pathways receives FDA breakthrough therapy designation for psilocybin therapy for treatment-resistant depression. Available at: https:\/\/www.prnewswire.com\/news-releases\/compass-pathways-receives-fda-breakthrough-therapy-designation-for-psilocybin-therapy-for-treatment-resistant-depression-834088100.html (accessed 1 April 2024)."},{"key":"e_1_3_3_53_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-023-02455-9"},{"key":"e_1_3_3_54_1","first-page":"1","article-title":"Psychedelic-assisted treatment for substance use disorder: A narrative systematic review","author":"Piper T","year":"2025","unstructured":"Piper T, Small F, Brown S, et al. (2025) Psychedelic-assisted treatment for substance use disorder: A narrative systematic review. Addiction 1\u201324.","journal-title":"Addiction"},{"key":"e_1_3_3_55_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.14530"},{"key":"e_1_3_3_56_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2023.1133414"},{"key":"e_1_3_3_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2024.115880"},{"key":"e_1_3_3_58_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2017.00974"},{"key":"e_1_3_3_59_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881119855974"},{"key":"e_1_3_3_60_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881116675512"},{"key":"e_1_3_3_61_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000000436"},{"key":"e_1_3_3_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2023.03.031"},{"key":"e_1_3_3_63_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2019.00138"},{"key":"e_1_3_3_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(24)00333-X"},{"key":"e_1_3_3_65_1","volume-title":"The Yale Manual for Psilocybin-Assisted Therapy of Depression (Using Acceptance and Commitment Therapy as a Therapeutic Frame)","author":"Sloshower J","year":"2020","unstructured":"Sloshower J, Guss J, Krause R (2020) The Yale Manual for Psilocybin-Assisted Therapy of Depression (Using Acceptance and Commitment Therapy as a Therapeutic Frame)."},{"key":"e_1_3_3_66_1","doi-asserted-by":"publisher","DOI":"10.1177\/02698811231154852"},{"key":"e_1_3_3_67_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005053-198410000-00001"},{"key":"e_1_3_3_68_1","doi-asserted-by":"publisher","DOI":"10.1177\/0706743720970860"},{"key":"e_1_3_3_69_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2021.586682"},{"key":"e_1_3_3_70_1","unstructured":"Third Wave (n.d.a) Ketamine Guide\u2014The ketamine experience therapeutic use and more. Available at: https:\/\/thethirdwave.co\/psychedelics\/ketamine\/ (accessed 1 April 2024)."},{"key":"e_1_3_3_71_1","unstructured":"Third Wave (n.d.b) MDMA Guide: MDMA dosage benefits and side effects. Available at: https:\/\/thethirdwave.co\/psychedelics\/mdma\/ (accessed 1 April 2024)."},{"key":"e_1_3_3_72_1","doi-asserted-by":"publisher","DOI":"10.1021\/acschemneuro.7b00074"},{"key":"e_1_3_3_73_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2022.101809"},{"key":"e_1_3_3_74_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcbs.2019.12.004"},{"key":"e_1_3_3_75_1","first-page":"279","article-title":"A systematic review of psychedelic-assisted psychotherapy for mental health: An evaluation of the current wave of research and suggestions for the future","volume":"7","author":"Wheeler SW","year":"2020","unstructured":"Wheeler SW, Dyer NL (2020) A systematic review of psychedelic-assisted psychotherapy for mental health: An evaluation of the current wave of research and suggestions for the future. Psychol Conscious Theory Res Pract 7: 279\u2013315.","journal-title":"Psychol Conscious Theory Res Pract"},{"key":"e_1_3_3_76_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-020-05692-9"}],"container-title":["Journal of Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/02698811251338214","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/02698811251338214","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/02698811251338214","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:12:12Z","timestamp":1777507932000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/02698811251338214"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,12]]},"references-count":75,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["10.1177\/02698811251338214"],"URL":"https:\/\/doi.org\/10.1177\/02698811251338214","relation":{},"ISSN":["0269-8811","1461-7285"],"issn-type":[{"value":"0269-8811","type":"print"},{"value":"1461-7285","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,12]]}}}